Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Depression

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    May 2023
  1. HARRIS E
    Ketamine Noninferior to Electroconvulsive Therapy For Depression.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9604.
    PubMed    


    March 2023
  2. HARRIS E
    Combining Drugs Improved Hard-to-Treat Depression in Older Adults.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3309.
    PubMed    


    February 2023
  3. LEICHSENRING F, Heim N, Leweke F, Spitzer C, et al
    Borderline Personality Disorder: A Review.
    JAMA. 2023;329:670-679.
    PubMed     Abstract available


    November 2022
  4. NELSON HD, Darney BG, Ahrens K, Burgess A, et al
    Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:1714-1729.
    PubMed     Abstract available


    October 2022
  5. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022 Oct 11. pii: 2797145. doi: 10.1001/jama.2022.16946.
    PubMed     Abstract available


  6. JIN J
    Screening for Depression and Suicide Risk in Children and Adolescents.
    JAMA. 2022 Oct 11. pii: 2797147. doi: 10.1001/jama.2022.18187.
    PubMed    


  7. BUKSTEIN OG
    Screening for Adolescent Depression and Suicide Risk.
    JAMA. 2022 Oct 11. pii: 2797148. doi: 10.1001/jama.2022.15223.
    PubMed    


  8. VISWANATHAN M, Wallace IF, Cook Middleton J, Kennedy SM, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022 Oct 11. pii: 2797146. doi: 10.1001/jama.2022.16310.
    PubMed     Abstract available


    August 2022
  9. GOODWIN RD, Davidson L
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders.
    JAMA. 2022;328:585.
    PubMed    


  10. HAN B, Tipperman D, Compton WM
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders-Reply.
    JAMA. 2022;328:585-586.
    PubMed    


    July 2022
  11. IOSIFESCU DV
    Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress.
    JAMA. 2022;328:146-148.
    PubMed    


  12. OSLIN DW, Lynch KG, Shih MC, Ingram EP, et al
    Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
    JAMA. 2022;328:151-161.
    PubMed     Abstract available


    June 2022
  13. SLOMSKI A
    Even Low Amounts of Physical Activity Reduce Depression Risk.
    JAMA. 2022;327:2066.
    PubMed    


    May 2022
  14. SLOMSKI A
    Antidepressant Combinations Compared With Monotherapy.
    JAMA. 2022;327:1641.
    PubMed    


    April 2022
  15. HAN B, Volkow ND, Blanco C, Tipperman D, et al
    Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019.
    JAMA. 2022;327:1566-1576.
    PubMed     Abstract available


  16. CHEN MH, Liang CS, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1291-1292.
    PubMed    


  17. LIANG CS, Tseng PT, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1290-1291.
    PubMed    


  18. OKEREKE OI, Mischoulon D, Manson JE
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression-Reply.
    JAMA. 2022;327:1292.
    PubMed    


    January 2022
  19. NIKNAM BA, Zubizarreta JR
    Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies.
    JAMA. 2022;327:173-174.
    PubMed    


  20. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    PubMed     Abstract available


    December 2021
  21. OKEREKE OI, Vyas CM, Mischoulon D, Chang G, et al
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    JAMA. 2021;326:2385-2394.
    PubMed     Abstract available


    November 2021
  22. ABBASI J
    Closed Loop Device May Alleviate Treatment-Resistant Depression.
    JAMA. 2021;326:1785.
    PubMed    


  23. CHEN MH, Tseng PT, Liang CS
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748.
    PubMed    


  24. HAHN SR
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748-1749.
    PubMed    


  25. BAUMGART P, Garrick T
    Depressive Symptom Assessment in Medically Ill Patients-Reply.
    JAMA. 2021;326:1749.
    PubMed    


  26. CHRISTENSEN J, Trabjerg BB, Sun Y, Dreier JW, et al
    Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children.
    JAMA. 2021;326:1725-1735.
    PubMed     Abstract available


    October 2021
  27. SLOMSKI A
    Pediatric Depression and Anxiety Doubled During the Pandemic.
    JAMA. 2021;326:1246.
    PubMed    


    September 2021
  28. SLOMSKI A
    Novel Oral Drug Rapidly Treats Postpartum Depression.
    JAMA. 2021;326:800.
    PubMed    


    August 2021

  29. A Simple Approach to Relieve Teens' Anxiety and Depression.
    JAMA. 2021;326:591.
    PubMed    


    June 2021
  30. BAUMGART P, Garrick T
    Assessment of Depressive Symptoms in Medically Ill Patients.
    JAMA. 2021;325:2497-2498.
    PubMed    


  31. LISS DT, Uchida T, Wilkes CL, Radakrishnan A, et al
    General Health Checks in Adult Primary Care: A Review.
    JAMA. 2021;325:2294-2306.
    PubMed     Abstract available


    May 2021
  32. TOROUS J
    Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
    JAMA. 2021;325:1839-1840.
    PubMed    


  33. ASPVALL K, Andersson E, Melin K, Norlin L, et al
    Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    JAMA. 2021;325:1863-1873.
    PubMed     Abstract available


  34. ARAYA R, Menezes PR, Claro HG, Brandt LR, et al
    Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
    JAMA. 2021;325:1852-1862.
    PubMed     Abstract available


    April 2021
  35. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    PubMed    


  36. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    PubMed    


  37. SLOMSKI A
    Low-Income African American Women With Hypertension and Depression.
    JAMA. 2021;325:1602.
    PubMed    


    March 2021
  38. BAGLEY SM
    I Am Not Burned Out.
    JAMA. 2021;325:1155-1156.
    PubMed    


  39. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    PubMed     Abstract available


    December 2020
  40. RUBIN R
    Postpartum Depression Persists Longer Than Previously Thought.
    JAMA. 2020;324:2475.
    PubMed    


  41. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    PubMed     Abstract available


    October 2020
  42. BAUM A, Wisnivesky J, Basu S, Siu AL, et al
    Association of Geographic Differences in Prevalence of Uncontrolled Chronic Conditions With Changes in Individuals' Likelihood of Uncontrolled Chronic Conditions.
    JAMA. 2020;324:1429-1438.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: